NBTY seals Leiner deal
This article was originally published in The Tan Sheet
Executive Summary
Nutritional supplement manufacturer and marketer NBTY announced July 14 it completed its purchase of substantially all Leiner Health Products' assets for $371 million (1"The Tan Sheet" June 16, 2008, p. 3)...
You may also be interested in...
NBTY Forced To Hike Prices By Leiner Integration Costs, Shrinking Margins
NBTY plans to raise prices for its Nature's Bounty brand dietary supplements in January 2009 following a 63.8 percent decrease in net income in its latest earnings period
NBTY Leiner Buy Intensifies Supplement Ingredient Competition
The dietary supplement ingredient supply market is set to become more competitive with NBTY's planned acquisition of Leiner Health Products
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.